Home
Tag
Harsher Singh
1 article
Results
Jubilant Pharmova Q2 Revenue Up 21% YoY
Jubilant Pharmova reported Q2 FY2027 revenue growth of 21% YoY to ₹2,370 Crores, driven by growth across all business segments. EBITDA for the quarter was ₹255 Crores, with margins impacted by SPECT p